Historique
Bulletin de Périodique
International Journal of Drug Policy , Vol.22, n°1 - January 2011
Paru le :
01/01/2011
Année
2011
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
• Group sex events amongst non-gay drug users: An understudied risk environment. Friedman S.R., Mateu-Gelabert P., Sandoval M., p. 1-8.
• Impact of training for healthcare professionals on how to manage an opioid overdose with naloxone: Effective, but dissemination is challenging. Mayet S., Manning V., Williams A., Loaring J., Strang J., p. 9-15.
• Infrequent opioid overdose risk reduction behaviours among young adult heroin users in cities with wide coverage of HIV prevention programmes. Neira-León M., Barrio G., Bravo M.J., Brugal M.T., de la Fuente L., Domingo-Salvany A., et al., p. 16-25.
• Prevalence and factors related to syringe sharing behaviours among female injecting drug users who are also sex workers in China. Gu J., Lau J.T.F., Chen H., Tsui H., Ling W., p. 26-33.
• Guidelines for better harm reduction: Evaluating implementation of best practice recommendations for needle and syringe programs (NSPs). Strike C., Watson T.M., Lavigne P., Hopkins S., Shore R., Young D., et al., p. 34-40.
• Adoption and utilization of sexually transmitted infections testing in outpatient substance abuse treatment facilities serving high risk populations in the U.S. Guerrero E.G., Cederbaum J.A., p. 41-48.
• A venue analysis of predictors of alcohol use prior to sexual intercourse among female sex workers in Senggigi, Indonesia. Safika I., Johnson T.P., Levy J.A., p. 49-55.
• "It's not rocket science, what I do": Self-directed harm reduction strategies among drug using ethno-racially diverse gay and bisexual men. Greenspan N.R., Aguinaldo J.P., Husbands W., Murray J., Ho P., Sutdhibhasilp N., et al., p. 56-62.
• Hospitalisation for an alcohol-related cause among injecting drug users in Scotland: Increased risk following diagnosis with hepatitis C infection. McDonald S.A., Hutchinson S.J., Bird S.M., Robertson C., Mills P.R., Dillon J.F., et al., p. 63-69.
• Treatment costs of hepatitis C infection among injection drug users in Canada, 2006-2026. Werb D., Wood E., Kerr T., Hershfield N., Palmer R.W.H., Remis R.S., p. 70-76.
• "Should I stay or should I go?" Coming off methadone and buprenorphine treatment. Winstock A.R., Lintzeris N., Lea T., p. 77-81.
• Next generation challenges: An overview of harm reduction 2010, IHRA's 21st conference. Russell S.J., McVeigh J., p. 82-86.
• Group sex events amongst non-gay drug users: An understudied risk environment. Friedman S.R., Mateu-Gelabert P., Sandoval M., p. 1-8.
• Impact of training for healthcare professionals on how to manage an opioid overdose with naloxone: Effective, but dissemination is challenging. Mayet S., Manning V., Williams A., Loaring J., Strang J., p. 9-15.
• Infrequent opioid overdose risk reduction behaviours among young adult heroin users in cities with wide coverage of HIV prevention programmes. Neira-León M., Barrio G., Bravo M.J., Brugal M.T., de la Fuente L., Domingo-Salvany A., et al., p. 16-25.
• Prevalence and factors related to syringe sharing behaviours among female injecting drug users who are also sex workers in China. Gu J., Lau J.T.F., Chen H., Tsui H., Ling W., p. 26-33.
• Guidelines for better harm reduction: Evaluating implementation of best practice recommendations for needle and syringe programs (NSPs). Strike C., Watson T.M., Lavigne P., Hopkins S., Shore R., Young D., et al., p. 34-40.
• Adoption and utilization of sexually transmitted infections testing in outpatient substance abuse treatment facilities serving high risk populations in the U.S. Guerrero E.G., Cederbaum J.A., p. 41-48.
• A venue analysis of predictors of alcohol use prior to sexual intercourse among female sex workers in Senggigi, Indonesia. Safika I., Johnson T.P., Levy J.A., p. 49-55.
• "It's not rocket science, what I do": Self-directed harm reduction strategies among drug using ethno-racially diverse gay and bisexual men. Greenspan N.R., Aguinaldo J.P., Husbands W., Murray J., Ho P., Sutdhibhasilp N., et al., p. 56-62.
• Hospitalisation for an alcohol-related cause among injecting drug users in Scotland: Increased risk following diagnosis with hepatitis C infection. McDonald S.A., Hutchinson S.J., Bird S.M., Robertson C., Mills P.R., Dillon J.F., et al., p. 63-69.
• Treatment costs of hepatitis C infection among injection drug users in Canada, 2006-2026. Werb D., Wood E., Kerr T., Hershfield N., Palmer R.W.H., Remis R.S., p. 70-76.
• "Should I stay or should I go?" Coming off methadone and buprenorphine treatment. Winstock A.R., Lintzeris N., Lea T., p. 77-81.
• Next generation challenges: An overview of harm reduction 2010, IHRA's 21st conference. Russell S.J., McVeigh J., p. 82-86.
Dépouillements
Ajouter le résultat à votre sélection
C. STRIKE ;
T. M. WATSON ;
P. LAVIGNE ;
S. HOPKINS ;
R. SHORE ;
D. YOUNG ;
L. LEONARD ;
P. MILLSON
|
2011
Dans International Journal of Drug Policy (Vol.22, n°1, January 2011) Article : Périodique
Dans International Journal of Drug Policy (Vol.22, n°1, January 2011) Article : Périodique
Background: The objective of this study was to evaluate needle and syringe program (NSP) policies and procedures before and after the dissemination of a set of best practice recommendations.
Methods: An on-line survey of 32 core NSP managers (1[...]
D. WERB ;
E. WOOD ;
T. KERR ;
N. HERSHFIELD ;
R. W. H. PALMER ;
R. S. REMIS
|
2011
Dans International Journal of Drug Policy (Vol.22, n°1, January 2011) Article : Périodique
Dans International Journal of Drug Policy (Vol.22, n°1, January 2011) Article : Périodique
Background Canadian injection drug users (IDUs) are at high risk of hepatitis C virus infection (HCV). However, little is known about the costs associated with their HCV-related medical treatment. We estimated the medical costs of treating HCV-i[...]